The trademark application EYEGM was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). Application under examination.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 42 with Platform as a service (PAAS) featuring computer software platforms for genetic research and gene therapy and providing a database of information relating to diseases and genetic information..